Skip to content

Clinical trials

Hypercholesterolemia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Poland Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20061
20081
20101
20111
20121
20135
20142
20151
20166
20172
20181
20191
20212
20223
20233
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Active, not recruiting3
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
Novartis Pharmaceuticals5
Sanofi4
Takeda3
Eli Lilly and Company2
Kowa Research Europe2
NewAmsterdam Pharma2
AronPharma Sp. z o. o.1
AstraZeneca1
Collegium Medicum w Bydgoszczy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia39
Dyslipidemias14
Hyperlipidemias9
Atherosclerosis4
Hyperlipoproteinemia Type II4
Cardiovascular Diseases3
Coronary Artery Disease3
Diabetes Mellitus2
Homozygous Familial Hypercholesterolemia2
Hypertension2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.